新型抗毒蕈碱药物：控制膀胱功能且口干症状较轻。
The newer antimuscarinic drugs: bladder control with less dry mouth.
作者信息
Appell Rodney A
机构信息
Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
出版信息
Cleve Clin J Med. 2002 Oct;69(10):761, 765-6, 768-9. doi: 10.3949/ccjm.69.10.761.
PMID:12371799
Abstract
Two newer antimuscarinic anticholinergic drugs--tolterodine and extended-release oxybutynin--are approximately as effective in treating overactive bladder as immediate-release oxybutynin, but are more tolerable. I review clinical trial data on the newer agents.
摘要
两种新型抗毒蕈碱类抗胆碱能药物——托特罗定和缓释奥昔布宁——在治疗膀胱过度活动症方面的效果与速释奥昔布宁大致相同，但耐受性更好。我回顾了关于这些新型药物的临床试验数据。
Zotero 插件